T1-weighted cine FLASH is superior to IR imaging of post-infarction myocardial viability at 4.7T

Journal of Cardiovascular Magnetic Resonance

Volumn 8, Issue 2, 2006, Pages 345-352

  Thomas, D ^a   Dumont, C ^a   Pickup, S ^a   Misselwitz, B ^b   Zhou, R ^a   Horowitz, J ^a   Ferrari, V ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BAYER PHARMA AG   (Germany)

^c University of PA Medical Center   (United States)

Author keywords

Comparative Studies MR; Experimental Studies; Heart; Infarction MR

Indexed keywords

CONTRAST MEDIUM; GADOPHRIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINERADIOGRAPHY; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; IMAGE ENHANCEMENT; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RELIABILITY; SIGNAL NOISE RATIO; STANDARD; STATISTICAL SIGNIFICANCE;

ANIMALS; CONTRAST MEDIA; GADOLINIUM DTPA; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; METALLOPORPHYRINS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644827270     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640500451986     Document Type: Article

References (18)

1. Jia LG, Donnet C, Bogaev RC, Blatt RJ, McKinney CE, Day KH, Berr SS, Jones LR, Moorman JR, Sweadner KJ, Tucker AL. Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice. Am J Physiol Heart Circ Physiol 2005;288:H1982-8.
2. Nahrendorf M, Hiller K-H, Hu K, Ertl G, Haase A, Bauer WR. Cardiac magnetic resonance imaging in small animal models of human heart failure. Medical Image Analysis 2003;7:369-75.
3. Nahrendorf M, Spindler M, Hu K, Bauer L, Ritter O, Nordbeck P, Quaschning T, Hiller KH, Wallis J, Ertl G, Bauer WR, Neubauer S. Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. Cardiovasc Res 2005;65:419-27.
4. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34.
5. Yang Z, Berr SS, Gilson WD, Toufektsian MC, French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 2004;109:1161-7.
6. Nahrendorf M, Wiesmann F, Hiller KH, Hu K, Waller C, Ruff J, Neubauer S, Haase A, Ertl G, Bauer WR. Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats. J Magn Reson Imaging 2001;14:547-55.
7. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
8. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
9. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23.
10. Chapon C, Lemaire L, Franconi F, Marescaux L, Legras P, Denizot B, Le Jeune JJ. Assessment of myocardial viability in rats: evaluation of a new method using superparamagnetic iron oxide nanoparticles and Gd-DOTA at high magnetic field. Magn Reson Med 2004;52:932-6.
11. Saeed M, Wendland MF, Bremerich GL, Weinmann HJ, Higgins CB. Assessment of myocardial viability using standard extracellular and necrosis specific MR contrast media. Acad Radiol 2002;9 Suppl 1:S84-7.
12. Barkhausen J, Ebert W, Debatin JF, Weinmann HJ. Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits. J Am Coll Cardiol 2002;39:1392-8.
13. Schalla S, Wendland MF, Higgins CB, Ebert W, Saeed M. Accentuation of high susceptibility of hypertrophied myocardium to ischemia: complementary assessment of Gadophrin-enhancement and left ventricular function with MRI. Magn Reson Med 2004;51:552-8.
14. Epstein FH, Yang Z, Gilson WD, Berr SS, Kramer CM, French BA. MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magn Reson Med 2002;48:399-403.
15. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5:505-14.
16. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-42.
17. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
18. Weiss CR, Aletras AH, London JF, Taylor JL, Epstein FH, Wassmuth R, Ballaban RS, Arai AE. Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast. Radiology 2003;226:723-30.